Quick Links

jewish general hospital

No increased heart failure with incretin-based drugs

Thu, 2016-03-24 11:17

McGill Newsroom

Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications

Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.

Contact Information

Contact: Tod Hoffman
Organization: Research Communications Officer - Lady Davis Institute for Medical Research
Email:
Office Phone: 514-340-8222 x 8661
Mobile Phone: 514-433-3500
Source Site: /newsroom

Diabetes drug found not to cause pancreatic cancer

Canada’s national drug safety network conducted the largest study ever to determine whether incretin-based drugs are associated with pancreatic cancer. Researchers concluded that no such association exists.
Mon, 2016-02-22 14:03

By Tod Hoffman, Lady Davis Institute for Medical Research

The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ).

The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.

Contact Information

Contact: Tod Hoffman
Organization: Research Communications Officer - Lady Davis Institute for Medical Research
Email:
Office Phone: 514-340-8222 x 8661
Mobile Phone: 514-433-3500
Source Site: /newsroom

11ième journée annuelle de la recherche du département de psychiatrie/11th Annual JGH Department of Psychiatry research day

Fri, 2016-04-01 08:30 - 12:30
Jewish General Hospital : ICFP Amphitheatre, 4333, Chemin de la Côte Ste-Catherine, 3755 Cote St. Catherine Road Montreal Quebec Canada , H3T 1E2
Price: Free

SVP vous inscrire à/Please register at: www.jgh.ca/en/Research_Day_Registration

Source Site: /psychiatry

Treatment for dry eye disease based on McGill research

The new treatment promises to bring relief to over a 100 million people worldwide who suffer from chronic dry eye disease​
Thu, 2015-12-03 15:11

The discovery that tavilermide  induces the production of mucin, a crucial lubricant in tears, offers hope of relief to people who suffer from chronic dry eye disease. The invention and the development of a drug based on this small molecule was made by the team of Dr. H. Uri Saragovi, Senior Investigator at the Lady Davis Institute (LDI) at the Jewish General Hospital and Professor of Pharmacology at McGill University.

Contact Information

Contact: Tod Hoffman
Organization: Research Communications Officer - Lady Davis Institute
Email:
Office Phone: 514-340-8222 x 8661
Mobile Phone: 514-433-3500
Source Site: /newsroom

Clinical Trial for Type 1 Diabetes Begins at JGH, MUHC

Wed, 2015-11-25 15:57

Landmark Clinical Trial of a Novel Combination Treatment for Type 1 Diabetes Begins at Jewish General Hospital and McGill University Health Centre

Contact Information

Contact: Tod Hoffman
Organization: Research Communications Officer - Lady Davis Institute
Email:
Office Phone: 514-340-8222 x 8661
Mobile Phone: 514-433-3500
Source Site: /newsroom

Douglas Utting Lecture 2015

Mon, 2015-11-09 19:30 - 21:30
Jewish General Hospital : Amphitheatre - G43 (Ground Floor), 3755 Cote St. Catherine Road Montreal Quebec Canada , H3T 1E2
Price: Free
Source Site: /psychiatry

Novel gene implicated in osteoporosis

Using one of the world’s most extensive genetics data sets, an international research team led by Dr. Brent Richards of the Lady Davis Institute at the Jewish General Hospital has identified a novel gene implicated in osteoporosis
Mon, 2015-09-14 11:06

Category:
Source Site: /newsroom

Association between low vitamin D and MS

Having low levels of vitamin D doubles the risk of developing multiple sclerosis, an association that researchers conclude supports a causal relationship
Tue, 2015-08-25 16:16

Low levels of vitamin D significantly increase the risk of developing multiple sclerosis (MS), according to a study led by Dr. Brent Richards of the Lady Davis Institute at the Jewish General Hospital, and published in PLOS Medicine. This finding, the result of a sophisticated Mendelian randomization analysis, confirms a long-standing hypothesis that low vitamin D is strongly associated with an increased susceptibility to MS. This connection is independent of other factors associated with low vitamin D levels, such as obesity.

Contact Information

Contact: Emmanuelle Paciullo
Organization: Lady Davis Institute
Email:
Office Phone: 514-340-8222 x 4120
Category:
Source Site: /newsroom

Conference: JGH Child Psychiatry - Re-visioning the treatment of High Risk Children

Fri, 2015-10-02 08:30 - 17:00
Jewish General Hospital : Institute of Family and Community Psychiatry, Amphitheatre, 3755 Cote St. Catherine Road Montreal Quebec Canada , H3T 1E2

Jewish General Hospital - Child Psychiatry
Centre for Child Development and Mental Health

Source Site: /psychiatry

The Saul Albert Memorial Conference

Thu, 2015-10-22 19:30 - Fri, 2015-10-23 15:30
Jewish General Hospital : Amphitheatre (ground floor), 3755 Cote St. Catherine Road Montreal Quebec Canada , H3T 1E2
Source Site: /psychiatry